| Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ... Science 348 (6230), 124-128, 2015 | 8029 | 2015 |
| Genetic basis for clinical response to CTLA-4 blockade in melanoma A Snyder, V Makarov, T Merghoub, J Yuan, JM Zaretsky, A Desrichard, ... New England Journal of Medicine 371 (23), 2189-2199, 2014 | 4454 | 2014 |
| Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade N McGranahan, AJS Furness, R Rosenthal, S Ramskov, R Lyngaa, ... Science 351 (6280), 1463-1469, 2016 | 2967 | 2016 |
| Patterns and rates of exonic de novo mutations in autism spectrum disorders BM Neale, Y Kou, L Liu, A Ma’Ayan, KE Samocha, A Sabo, CF Lin, ... Nature 485 (7397), 242-245, 2012 | 2008 | 2012 |
| Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses KB Chiappinelli, PL Strissel, A Desrichard, H Li, C Henke, B Akman, ... Cell 162 (5), 974-986, 2015 | 1712 | 2015 |
| Microduplications of 16p11. 2 are associated with schizophrenia SE McCarthy, V Makarov, G Kirov, AM Addington, J McClellan, S Yoon, ... Nature genetics 41 (11), 1223-1227, 2009 | 814 | 2009 |
| Sensitive and accurate detection of copy number variants using read depth of coverage S Yoon, Z Xuan, V Makarov, K Ye, J Sebat Genome research 19 (9), 1586-1592, 2009 | 739 | 2009 |
| The Sac1 domain of SYNJ1 identified mutated in a family with early‐onset progressive Parkinsonism with generalized seizures CE Krebs, S Karkheiran, JC Powell, M Cao, V Makarov, H Darvish, ... Human mutation 34 (9), 1200-1207, 2013 | 373 | 2013 |
| High frequencies of de novo CNVs in bipolar disorder and schizophrenia D Malhotra, S McCarthy, JJ Michaelson, V Vacic, KE Burdick, S Yoon, ... Neuron 72 (6), 951-963, 2011 | 367 | 2011 |
| Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia V Vacic, S McCarthy, D Malhotra, F Murray, HH Chou, A Peoples, ... Nature 471 (7339), 499-503, 2011 | 364 | 2011 |
| Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival. LG Morris, N Riaz, A Desrichard, Y Şenbabaoğlu, AA Hakimi, V Makarov, ... Oncotarget 7 (9), 10051-10063, 2016 | 291 | 2016 |
| Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunological Markers E Knudsen, P Vail, U Balaji, H Ngo, IW Botros, V Makarov, N Riaz, ... Clinical Cancer Research, clincanres. 0162.2017, 2017 | 179 | 2017 |
| Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer MG Dalin, A Desrichard, N Katabi, V Makarov, LA Walsh, KW Lee, ... Clinical Cancer Research, clincanres. 0637.2016, 2016 | 173 | 2016 |
| The role of neoantigens in response to immune checkpoint blockade N Riaz, L Morris, JJ Havel, V Makarov, A Desrichard, TA Chan International immunology 28 (8), 411-419, 2016 | 162 | 2016 |
| Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy N Riaz, JJ Havel, SM Kendall, V Makarov, LA Walsh, A Desrichard, ... Nature Genetics 48 (11), 1327-1329, 2016 | 135 | 2016 |
| Analysis of Rare, Exonic Variation amongst Subjects with Autism Spectrum Disorders and Population Controls E Zeggini, L Liu, A Sabo, BM Neale, U Nagaswamy, C Stevens, E Lim, ... Public Library of Science (PLoS), 2013 | 106* | 2013 |
| Analysis of rare, exonic variation amongst subjects with autism spectrum disorders and population controls L Liu, A Sabo, BM Neale, U Nagaswamy, C Stevens, E Lim, CA Bodea, ... PLoS Genet 9 (4), e1003443, 2013 | 106 | 2013 |
| Transcriptional diversity of long-term glioblastoma survivors NK Gerber, A Goenka, S Turcan, M Reyngold, V Makarov, K Kannan, ... Neuro-oncology 16 (9), 1186-1195, 2014 | 98 | 2014 |
| Family-based association tests for sequence data, and comparisons with population-based association tests I Ionita-Laza, S Lee, V Makarov, JD Buxbaum, X Lin European Journal of Human Genetics 21 (10), 1158-1162, 2013 | 96 | 2013 |
| Transcriptional mechanisms of resistance to anti-PD-1 therapy ML Ascierto, A Makohon-Moore, EJ Lipson, JM Taube, TL McMiller, ... Clinical Cancer Research, clincanres. 0270.2016, 2017 | 80 | 2017 |
